February 28, 2022: Safety Bulletin - Sharing Matters! Reported Concern Results in Safer Jardiance Product Labelling
ISMP Canada received a report from HealthPRO Procurement Services Inc. about a potential patient safety concern with packaging for Jardiance (empagliflozin) tablets. The report described insufficient information on the blister card labels for this drug after a change to the product's package. Read more ...
